Technology
In many parts of the world, TB is diagnosed using
approaches developed more than a century ago. Existing technologies
have considerable limitations.
Chemogen’s break-through technology presents
an entirely new approach to detecting TB.
Clinical studies have demonstrated
the test’s superior performance over the widely-used sputum
smear test in HIV-positive patients. Chemogen’s test is also
able to detect extrapulmonary tuberculosis, something that the sputum
smear test and bacterial culture is unable to do.
The distinguishing features of Chemogen’s test compared
to competing technologies are:
-
Higher detection rate than the sputum smear
test in HIV/TB populations
-
Detects the presence of the active TB antigen
-
Detects both active pulmonary and extra-pulmonary
TB in HIV patients
-
User-friendly
-
Rapid
-
Robust
-
Affordable
|
